We anticipate steady progress in the growing litigation involving this medication, and will be monitoring developments closely.
(PRWEB) March 21, 2015
More than 300 Xarelto lawsuits (http://www.xareltolawsuit2015.com/) are now pending in a federal multidistrict litigation in the U.S. District Court, Eastern District of Louisiana according to a Docket Report issued by the U.S. Judicial Panel on Multidistrict Litgiation on March 16, 2015.
“Our Firm is currently representing a number of Xarelto lawsuit plaintiffs in federal court. We anticipate steady progress in the growing litigation involving this medication, and will be monitoring developments closely,” says Sandy A. Liebhard, a partner at the nationwide law firm, Bernstein Liebhard LLP, who is representing clients who have allegedly been harmed by defective medical devices and drugs including Xarelto.
Court records indicate that Xarelto lawsuits currently pending in U.S. courts similarly accuse Johnson & Johnson and Bayer Healthcare of failing to adequately warn about the severity of complications that may stem from its use, which may include but are not limited to life-threatening episodes of internal bleeding, as well as deep vein thrombosis, pulmonary embolism and strokes. (In Re: Xarelto Products Liability Litigation, No. 2592)
Xarelto is an anticoagulant approved in 2011 by the U.S. Food and Drug Administration (FDA) to reduce the risk of blood clots in people with atrial fibrillation, as well as to treat deep vein thrombosis and pulmonary embolism, in addition to other uses.
Court records indicate that the medication has come under scrutiny since then, however, for its alleged potential to cause episodes of internal bleeding that may turn life-threatening since there is no available antidote to reverse their effects. This complication and several others have been alleged in Xarelto lawsuits now pending in the U.S. District Court, Eastern District of Louisiana. Included in their claims are allegations that Johnson & Johnson and Bayer concealed vital safety information from the public and have been improperly marketing their product since 2011 as a more convenient alternative to warfarin, a similar blood thinner that has been on the market for over half a century.
According to court documents, the federal multidistrict litigation (MDL) established for Xarelto lawsuits was created in the U.S. District Court, Eastern District of Louisiana in December 2014 after a federal panel transferred a number of similar cases to the court.
Xarelto patients who allegedly experienced internal bleeding episodes caused by the blood thinner may be entitled to compensation for out-of-pocket medical expenses, lost wages, pain and suffering and other damages. Learn more about the risk for Xarelto internal bleeding when you visit Bernstein Liebhard LLP’s website, or call 800-511-5092 to schedule a free, no obligation case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP